Short description
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body.
Description
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body. The company’s innovative technology platform utilizes cell-conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address underserved, multi-billion US dollar global markets.
It was founded in 2007 by Dr. Gail Naughton and is headquartered in San Diego, California.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
San Diego, California, United States, North America
Founded on
January 1, 2007
Exited on
May 27, 2020
Went public on
May 27, 2020
Stock symbol
HSTO
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noway Youcantaccess, Noaccess, No Way, Noaccess, Noway Youcantaccess, Noaccess, Noaccess
Sign in for full access
Founders
Gail K. Naughton